Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 22795363)

1.

Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases.

Trentin C, Dominelli V, Maisonneuve P, Menna S, Bazolli B, Luini A, Cassano E.

Breast. 2012 Oct;21(5):635-40. doi: 10.1016/j.breast.2012.06.009. Epub 2012 Jul 12.

PMID:
22795363
2.

Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.

Dillon MF, McDermott EW, Quinn CM, O'Doherty A, O'Higgins N, Hill AD.

J Surg Oncol. 2006 Jun 1;93(7):559-63.

PMID:
16705731
3.

Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.

Kim J, Han W, Lee JW, You JM, Shin HC, Ahn SK, Moon HG, Cho N, Moon WK, Park IA, Noh DY.

Breast. 2012 Oct;21(5):641-5. doi: 10.1016/j.breast.2012.06.012. Epub 2012 Jun 30.

PMID:
22749854
4.

Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.

Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano SH, Feig BW, Ames FC, Kuerer HM.

J Am Coll Surg. 2005 Apr;200(4):516-26.

PMID:
15804465
5.

Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.

Moore KH, Sweeney KJ, Wilson ME, Goldberg JI, Buchanan CL, Tan LK, Liberman L, Turner RR, Lagios MD, Cody Iii HS, Giuliano AE, Silverstein MJ, Van Zee KJ.

Ann Surg Oncol. 2007 Oct;14(10):2911-7. Epub 2007 Jun 28.

PMID:
17597346
6.

Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.

Goyal A, Douglas-Jones A, Monypenny I, Sweetland H, Stevens G, Mansel RE.

Breast Cancer Res Treat. 2006 Aug;98(3):311-4. Epub 2006 Mar 22.

PMID:
16552627
7.

Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.

Tan JC, McCready DR, Easson AM, Leong WL.

Ann Surg Oncol. 2007 Feb;14(2):638-45. Epub 2006 Nov 14.

PMID:
17103256
8.

Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ.

Osako T, Iwase T, Ushijima M, Horii R, Fukami Y, Kimura K, Matsuura M, Akiyama F.

Cancer Sci. 2014 May;105(5):576-82. doi: 10.1111/cas.12381. Epub 2014 Mar 26.

PMID:
24533797
10.

Predictors of invasive breast cancer in ductal carcinoma in situ initially diagnosed by core biopsy.

Chan MY, Lim S.

Asian J Surg. 2010 Apr;33(2):76-82. doi: 10.1016/S1015-9584(10)60013-9.

PMID:
21029943
11.

Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.

Park HS, Park S, Cho J, Park JM, Kim SI, Park BW.

J Surg Oncol. 2013 Mar;107(4):388-92. doi: 10.1002/jso.23273. Epub 2012 Sep 24.

PMID:
23007901
12.

Sentinel lymph node biopsy in patients with pure and high-risk ductal carcinoma in situ of the breast.

D'Eredità G, Giardina C, Napoli A, Ingravallo G, Troilo VL, Fischetti F, Berardi T.

Tumori. 2009 Nov-Dec;95(6):706-11.

PMID:
20210234
14.

Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.

Han JS, Molberg KH, Sarode V.

Breast J. 2011 May-Jun;17(3):223-9. doi: 10.1111/j.1524-4741.2011.01069.x. Epub 2011 Mar 24.

PMID:
21545433
15.

Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.

Schulz S, Sinn P, Golatta M, Rauch G, Junkermann H, Schuetz F, Sohn C, Heil J.

Breast. 2013 Aug;22(4):537-42. doi: 10.1016/j.breast.2012.11.002. Epub 2012 Dec 11.

PMID:
23237921
16.

Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ.

Shapiro-Wright HM, Julian TB.

J Natl Cancer Inst Monogr. 2010;2010(41):145-9. doi: 10.1093/jncimonographs/lgq026. Review.

PMID:
20956820
17.

Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component.

Wasserberg N, Morgenstern S, Schachter J, Fenig E, Lelcuk S, Gutman H.

Arch Surg. 2002 Nov;137(11):1249-52.

PMID:
12413311
18.

Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?

Doyle B, Al-Mudhaffer M, Kennedy MM, O'Doherty A, Flanagan F, McDermott EW, Kerin MJ, Hill AD, Quinn CM.

J Clin Pathol. 2009 Jun;62(6):534-8. doi: 10.1136/jcp.2008.061457. Epub 2009 Feb 3.

PMID:
19190009
19.

Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.

Tunon-de-Lara C, Giard S, Buttarelli M, Blanchot J, Classe JM, Baron M, Monnier B, Houvenaeghel G.

Breast J. 2008 Mar-Apr;14(2):135-40. doi: 10.1111/j.1524-4741.2007.00543.x.

PMID:
18315691
20.

Treatment and survival of female patients with nonpalpable breast carcinoma.

Tinnemans JG, Wobbes T, Holland R, Hendriks JH, Van der Sluis RF, De Boer HH.

Ann Surg. 1989 Feb;209(2):249-53.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk